A braided cancer river connects tumor heterogeneity and precision medicine Journal Article


Authors: Hsieh, J. J.; Cheng, E. H.
Article Title: A braided cancer river connects tumor heterogeneity and precision medicine
Abstract: With the ever-increasing complexity of tumor heterogeneity (TH) discovered through cancer genome sequencing, it is apparent that TH has become the biggest hurdle for precision cancer therapeutics. Through studying the genomics of exceptional responders to targeted therapeutic agents in kidney cancer, we demonstrated parallel convergent gene/pathway/capability/function evolution of kidney cancer in the context of TH, which prompted us to propose a new cancer evolution model "the braided cancer river model". Based on this model, we might be able to outsmart a given cancer type within an individual patient through simultaneously inhibiting preferred parallel pathways or sequential nodes. Thus, the goals of this perspective are to define tumor heterogeneity, discuss tumor evolution, introduce braided cancer river model, and improve precision medicine.
Keywords: evolution; kidney cancer; everolimus; therapy; mtor; renal-cell carcinoma; guide; tumor heterogeneity; mtor inhibitors; hallmarks; precision medicine; braided cancer river model; vegf inhibitors; branched evolution; parallel convergent gene/pathway/capability/function evolution
Journal Title: Clinical and Translational Medicine
Volume: 5
ISSN: 2001-1326
Publisher: John Wiley & Sons  
Date Published: 2016-10-01
Start Page: 42
Language: English
ACCESSION: WOS:000391952100003
DOI: 10.1186/s40169-016-0123-4
PROVIDER: wos
PMCID: PMC5073086
PUBMED: 27766604
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. James J Hsieh
    125 Hsieh
  2. Emily H Cheng
    78 Cheng